[ad_1]
Mechanism of Action (Active Immunotherapy and Passive Immunotherapy) T Cell Immunotherapy Market research report, By Product Class (Bispecific Antibodies, Cytokines, Monoclonal Antibodies, and Oncolytic Virus Therapy), By Therapy Type , by indication – Global forecasts to 2025 – Cumulative impact of COVID-19
New York, January 13, 2021 (GLOBE NEWSWIRE) – Reportlinker.com announces the publication of the report “T-Cell Immunotherapy Market Research Report by Mechanism Of Action, by Product Class, by Type of Therapy, by Indication – Global Forecast to 2025 – Impact cumulative COVID-19 “- https://www.reportlinker.com/p06007640/?utm_source=GNW
Market Statistics:
The report provides market size and forecast for five major currencies – USD, EUR, GBP, JPY, and AUD. It helps organizational leaders make better decisions when currency data is readily available.
1. The global T cell immunotherapy market is expected to grow from USD 4,184.98 million in 2020 to USD 7,606.66 million by the end of 2025.
2. The global T cell immunotherapy market is expected to grow from € 3,669.47 million in 2020 to € 6,669.67 million by the end of 2025.
3. The global T cell immunotherapy market is expected to grow from £ 3,262.17million in 2020 to £ 5,929.35million by the end of 2025.
4. The global T cell immunotherapy market is expected to grow from JPY 446,644.26 million in 2020 to JPY 811,824.22 million by the end of 2025.
5. The global T cell immunotherapy market is expected to grow from AU $ 6,077.15 million in 2020 to AU $ 11,045.89 million by the end of 2025.
Market segmentation and coverage:
This research report categorizes T Cell Immunotherapy to forecast revenue and analyze trends in each of the following submarkets:
Based on Mechanism of Action, T Cell Immunotherapy Market has investigated active immunotherapy and passive immunotherapy.
On the basis of product class, the T Cell Immunotherapy market has studied Bispecific Antibodies, Cytokines, Monoclonal Antibodies, and Oncolytic Virus Therapy.
Based on the type of therapy, the T cell immunotherapy market has studied through CAR-T, TCR and TIL.
Based on the indication, the T Cell Immunotherapy Market investigated B-cell malignant tumors, liver cancer, prostate cancer, and renal carcinoma.
“Asia-Pacific is expected to experience the strongest growth during the forecast period”
On the basis of geography, the T cell immunotherapy market studied in Americas, Asia-Pacific and Europe, Middle East and Africa. The region of the Americas studied through Argentina, Brazil, Canada, Mexico and the United States. The Asia-Pacific region studied in Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea and Thailand. The Europe, Middle East and Africa region studied through France, Germany, Italy, the Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates and United Kingdom. Europe, Middle East and Africa occupied the largest size in the T-cell immunotherapy market in 2020. On the other hand, Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company usability profiles:
The report deeply explores the significant recent developments of leading vendors and innovation profiles in the global T cell immunotherapy market including Adaptimmune Therapeutics, Apac Biotech, Atara Biotherapeutics, Autolus, Bluebird bio, CARsgen Therapeutics, Cellectis, Chimera Bioengineering, Dendreon Pharmaceuticals LLC, Eureka Therapeutics, Gilead Sciences, Inc., Green Cross Corp, Innovative Cellular Therapeutics, Juno Therapeutics, JW CreaGene Co., Ltd, Kite Pharma, Lava Therapeutics, Lion Biotechnologies, Lyell Immunopharma, Nanjing Legend Pharmaceutical & Chemical , Neogene Therapeutics, NeoTX Therapeutics, Novartis AG, Oxford Vacmedix, Poseida Therapeutics, Sinobioway Cell Therapy, TScan Therapeutics, Xenetic Biosciences, Xyphos and ZIOPHARM Oncology.
Cumulative impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected nearly all industries, so for and, the long-term effects are expected to impact the growth of the industry during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of the underlying issues of COVID-19 and potential avenues ahead. The report provides insights on COVID-19 considering changes in consumer behavior and demand, purchasing patterns, supply chain diversion, dynamics of current market forces, and significant government interventions . The updated study provides information, analysis, estimates and forecasts, considering the impact of COVID-19 on the market.
FPNV 360iResearch ™ Positioning Matrix:
The FPNV 360iResearch ™ Positioning Matrix assesses and categorizes the T cell immunotherapy market vendors on the basis of business strategy (company growth, industry coverage, financial viability, and channel support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that helps businesses make better decisions and understand the competitive landscape.
360iResearch ™ competitive strategic window:
360iResearch ™ Competitive Strategy Window analyzes the competitive landscape in terms of markets, applications and geographies. 360iResearch ™ competitive strategic window helps the vendor define an alignment or fit between their capabilities and future growth opportunities. During a forecast period, it defines the optimal or favorable suitability for suppliers to adopt successive merger and acquisition strategies, geographic expansion, research and development and new introduction strategies. products to further expand and grow the business.
The report provides information on the following pointers:
1. Market penetration: provides comprehensive information on the market offered by the major players
2. Market Development: Provides detailed information on lucrative emerging markets and analyzes the markets
3. Market diversification: provides detailed information on new product launches, untapped geographies, recent developments and investments
4. Assessment and Competitive Intelligence: provides a comprehensive assessment of market shares, strategies, products and manufacturing capabilities of key players
5. Product development and innovation: provides intelligent information on future technologies, R&D activities and new product developments
The report answers questions such as:
1. What is the market size and forecast for the global T cell immunotherapy market?
2. What are the inhibitory factors and impact of COVID-19 on the global T cell immunotherapy market during the forecast period?
3. What are the products / segments / applications / areas to invest in during the forecast period of the global T Cell Immunotherapy Market?
4. What is the competitive strategic window for opportunities in the global T cell immunotherapy market?
5. What are the technological trends and regulatory frameworks in the global T cell immunotherapy market?
6. What are the strategic fads and moves considered appropriate for entering the global T cell immunotherapy market?
Read the full report: https://www.reportlinker.com/p06007640/?utm_source=GNW
About Reportlinker
ReportLinker is an award winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
__________________________
CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
Source link
